|
Volumn 9, Issue 6, 2000, Pages 905-911
|
Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER ANTIBODY;
CYTOKERATIN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY 45B B3;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANTIBODY DETECTION;
ARTICLE;
BONE MARROW CELL;
BREAST CANCER;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOCYTOCHEMISTRY;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN DETERMINATION;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
SURVIVAL TIME;
ACTUARIAL ANALYSIS;
AGED;
BONE MARROW;
BREAST NEOPLASMS;
COLORECTAL NEOPLASMS;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
KERATINS;
MALE;
MULTIVARIATE ANALYSIS;
NEOPLASM PROTEINS;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
PROSPECTIVE STUDIES;
RECURRENCE;
SURVIVAL RATE;
|
EID: 0034489456
PISSN: 15258165
EISSN: None
Source Type: Journal
DOI: 10.1089/152581600750062354 Document Type: Article |
Times cited : (29)
|
References (24)
|